Juncture Wealth Strategies’s Amphastar Pharmaceuticals AMPH Stock Holding History

Juncture Wealth Strategies’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,652	Closed	-$517K	–	131
2024 Q3	$517K	Sell	10,652 -568	-5%	-$24.9K	0.2%	70
2024 Q2	$449K	Sell	11,220 -340	-3%	-$14.1K	0.19%	70
2024 Q1	$508K	Sell	11,560 -7,236	-38%	-$374K	0.22%	61
2023 Q4	$1.16M	Buy	18,796 +1,085	+6%	+$57K	0.53%	37
2023 Q3	$815K	Buy	17,711 +1,795	+11%	+$97.9K	0.4%	53
2023 Q2	$915K	Sell	15,916 -5,537	-26%	-$245K	0.43%	42
2023 Q1	$804K	Buy	21,453 +9,148	+74%	+$300K	0.4%	47
2022 Q4	$345K	Buy	12,305 +97	+0.8%	+$2.82K	0.16%	87
2022 Q3	$343K	Buy	12,208 +6,379	+109%	+$208K	0.17%	85
2022 Q2	$203K	Buy	+5,829	New	+$208K	0.1%	104

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Juncture Wealth Strategies's AMPH Position: Q4 2024 in Review

Juncture Wealth Strategies sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2024, closing a stake of 10,652 shares — an estimated $517K sold.

Juncture Wealth Strategies first reported a position in AMPH in Q2 2022 and held it in 10 quarters. The position peaked at $1.16M in Q4 2023. 263 funds tracked by Wall St. Rank hold AMPH as of Q4 2024.

Juncture Wealth Strategies reported no remaining Amphastar Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Juncture Wealth Strategies sold 10,652 Amphastar Pharmaceuticals shares in Q4 2024, an estimated $517K.
Juncture Wealth Strategies first reported a position in Amphastar Pharmaceuticals in Q2 2022 and held it in 10 quarters.
Juncture Wealth Strategies's Amphastar Pharmaceuticals position peaked at $1.16M in Q4 2023.
263 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2024.

Based on Juncture Wealth Strategies's 13F filing for Q4 2024, filed 21 Jan 2025.